Impel Neuropharma Acute Migraine Treatment
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…
FDA
FDA’s Policy On Dry Heat For Respirators Re-Use
On November 25, the U.S. Food and Drug Administration (FDA) issued guidance on the use of dry heat to help support the single-user reuse of…
Pfizer And Biontech EUA For COVID-19 Vaccine
On November 20, Pfizer Inc. and BioNTech SE announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use…
Drug Combination For Treatment Of COVID-19
On November 20, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the…
Multi-Year Study to Enhance Food Safety
Recently the U.S. Food and Drug Administration (FDA) announced about a new multi-year study to enhance food safety. The launch of this study follows a…
FDA Investigation Of A Third E. coli Outbreak
On November 12, was announced that the FDA (Food and Drug Administration of the U.S.) and CDC (Centers for Disease Control and Prevention), in collaboration…
Monoclonal Antibody For COVID-19 Treatment Is Authorized By The FDA
The Food and Drug Administration of the U.S. (FDA) recently authorized monoclonal antibody for treatment of COVID-19. On November 9 FDA okayed an emergency use…
FDA Is Finalizing Insanitary Conditions Guidance
On Friday, November 6, The FDA (U.S. Food and Drug Administration) reported about efforts of protecting patients from exposure to poor quality compounded drugs by…
Pulse Oximeters and Oxygen Concentrators
Recently, pulse oximeters and oxygen concentrators became more popular, thanks to the coronavirus infection, that’s why Food and Drug Administration of the U.S. (FDA) drew…
FDA Warning Letters
On October 23, FDA (U.S. Food and Drug Administration) issued three FDA warning letters jointly with the Federal Trade Commission (FTC) to Peterson Research Laboratories…